123I Scintigraphy Mirror Image of Graves Disease Induced by Radioiodine Treatment for Toxic Adenoma

Clin Nucl Med. 2022 Feb 1;47(2):e197-e198. doi: 10.1097/RLU.0000000000003884.

Abstract

A 61-year-old woman presenting with hyperthyroidism received 131I therapy for a toxic adenoma diagnosed by 123I scintigraphy. Six months later, the patient had a relapse of hyperthyroidism, and 123I scintigraphy showed a mirror image of the first scintigraphy: a high and diffuse uptake in the thyroid gland except for the previously treated nodule. Graves disease was confirmed by elevated thyrotropin receptor antibodies. The patient was cured by a second radioiodine therapy. Radioiodine-induced Graves disease may occur within 6 months of 131I treatment of toxic adenoma and can be treated with a second line of 131I.

Publication types

  • Case Reports

MeSH terms

  • Adenoma*
  • Female
  • Graves Disease*
  • Humans
  • Hyperthyroidism*
  • Iodine Radioisotopes
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Radionuclide Imaging

Substances

  • Iodine Radioisotopes
  • Iodine-131
  • Iodine-123